Actual pharmacological biotechnological innovations to improve the quality of patient’s life therapeutic and surgical profile

Abstract

Modern effective drugs which are obtained by using biotechnological genetic engineering methods presented in this article. The main use in surgical and therapeutic clinical practice presents: modern recombinant probiotic generation V Subalin, which was synthesized by Ukrainian scientists for pharmacological treatment of intestinal dysbiosis, recombinant alpha-interferons Roferon-A (alfa-2a) and Altevir (alfa-2b).